advertisement

Dementia

08 September 2010

Cancer drug points way to new Alzheimer's approach

An altered version of the cancer drug Gleevec could form the basis of a new class of drugs that block the development of brain-damaging plaques in Alzheimer's disease, U.S. researchers said on Wednesday

This article has not necessarily been edited by Health24.

 

Read Health24’s Comments Policy

Comment on this story
0 comments
Comments have been closed for this article.